2006
DOI: 10.1007/s00384-006-0092-y
|View full text |Cite
|
Sign up to set email alerts
|

Instrumental clinical restaging, pathological evaluation, and tumor regression grading: how to assess the response to neoadjuvant chemoradiotherapy for rectal cancer

Abstract: Our results lead us to consider only pathologic evaluation to determine the response to neoadjuvant treatment: the application of tumor regression grading on the specimens obtained after combined neoadjuvant chemoradiotherapy and surgery is useful to plan a better therapeutic strategy on the ground of a quantitative evaluation of the response to neoadjuvant treatment; it shows it is an important comparable pathological feature, useful in comparing different protocols' results and differences between patient's … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2011
2011
2019
2019

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 33 publications
0
3
0
Order By: Relevance
“…In fact, early-stage tumors (ie, T1/T2) have excellent prognosis and are suitably treated by surgery alone. 75 In contrast, locally advanced disease, defined as tumor with transmural extension (ie, T3/T4) or tumor involving the locoregional lymph nodes (ie, N1/N2), has been associated with a high rate of local recurrence of about 25% in patients treated with surgery alone. 76 In 1982, Heald et al 77 introduced TME, reducing the local relapse rate to 7% and increasing the anal sphincter preservation rate by more than 20%.…”
Section: Colorectal Cancermentioning
confidence: 99%
“…In fact, early-stage tumors (ie, T1/T2) have excellent prognosis and are suitably treated by surgery alone. 75 In contrast, locally advanced disease, defined as tumor with transmural extension (ie, T3/T4) or tumor involving the locoregional lymph nodes (ie, N1/N2), has been associated with a high rate of local recurrence of about 25% in patients treated with surgery alone. 76 In 1982, Heald et al 77 introduced TME, reducing the local relapse rate to 7% and increasing the anal sphincter preservation rate by more than 20%.…”
Section: Colorectal Cancermentioning
confidence: 99%
“…Some authors showed that both 5-year overall and diseasefree survival rates were lower in patients with neoplastic mesorectal microfoci [24]. In the same way, several studies showed that a pCR was associated with lower rates of local recurrence [25][26][27]. It can be hypothesized that this better oncological outcome could be explained by the lower rate of vascular and/or perineural invasion observed in the mesorectum of responder patients.…”
Section: Discussionmentioning
confidence: 97%
“…As reported in other studies publications, when the rectoscopy strictly fulfils the criteria of a cCR and a negative biopsy is obtained, we can predict the probability of encountering a pCR. [ 24 25 26 ] Suzuki et al demonstrated that morphological changes on rectoscopy were significantly related to the degree of tumor shrinkage, but they only had a 2% pCR and failed to establish a statistically significant relationship between cCR and pCR. García-Aguilar et al[ 27 ] present similar data among patients with cT2N0 undergoing CRT where >90% cCR corresponded to ypT0 after local excision.…”
Section: Discussionmentioning
confidence: 99%